Symptoms of overdose include nausea and vomiting, and withdrawal bleeding may occur in females.
The 3-cyclopentyl ether of ethinyl estradiol.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Prasterone | The risk or severity of adverse effects can be increased when Prasterone is combined with Quinestrol. |
| Exemestane | The therapeutic efficacy of Exemestane can be decreased when used in combination with Quinestrol. |
| Hyaluronidase (ovine) | The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Quinestrol. |
| Hyaluronidase (human recombinant) | The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Quinestrol. |
| Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Quinestrol. |
| Lenalidomide | Quinestrol may increase the thrombogenic activities of Lenalidomide. |
| Ospemifene | The risk or severity of adverse effects can be increased when Quinestrol is combined with Ospemifene. |
| Ropinirole | Quinestrol may increase the excretion rate of Ropinirole which could result in a lower serum level and potentially a reduction in efficacy. |
| Thalidomide | Quinestrol may increase the thrombogenic activities of Thalidomide. |
| Cetuximab | Quinestrol may increase the thrombogenic activities of Cetuximab. |
| Human immunoglobulin G | Quinestrol may increase the thrombogenic activities of Human immunoglobulin G. |
| Omalizumab | Quinestrol may increase the thrombogenic activities of Omalizumab. |
| Adalimumab | Quinestrol may increase the thrombogenic activities of Adalimumab. |
| Gemtuzumab ozogamicin | Quinestrol may increase the thrombogenic activities of Gemtuzumab ozogamicin. |
| Indium In-111 satumomab pendetide | Quinestrol may increase the thrombogenic activities of Indium In-111 satumomab pendetide. |
| Infliximab | Quinestrol may increase the thrombogenic activities of Infliximab. |
| Trastuzumab | Quinestrol may increase the thrombogenic activities of Trastuzumab. |
| Rituximab | Quinestrol may increase the thrombogenic activities of Rituximab. |
| Basiliximab | Quinestrol may increase the thrombogenic activities of Basiliximab. |
| Muromonab | Quinestrol may increase the thrombogenic activities of Muromonab. |
| Digoxin Immune Fab (Ovine) | Quinestrol may increase the thrombogenic activities of Digoxin Immune Fab (Ovine). |
| Ibritumomab tiuxetan | Quinestrol may increase the thrombogenic activities of Ibritumomab tiuxetan. |
| Tositumomab | Quinestrol may increase the thrombogenic activities of Tositumomab. |
| Alemtuzumab | Quinestrol may increase the thrombogenic activities of Alemtuzumab. |
| Capromab pendetide | Quinestrol may increase the thrombogenic activities of Capromab pendetide. |
| Efalizumab | Quinestrol may increase the thrombogenic activities of Efalizumab. |
| Antithymocyte immunoglobulin (rabbit) | Quinestrol may increase the thrombogenic activities of Antithymocyte immunoglobulin (rabbit). |
| Natalizumab | Quinestrol may increase the thrombogenic activities of Natalizumab. |
| Palivizumab | Quinestrol may increase the thrombogenic activities of Palivizumab. |
| Daclizumab | Quinestrol may increase the thrombogenic activities of Daclizumab. |
| Bevacizumab | Quinestrol may increase the thrombogenic activities of Bevacizumab. |
| Technetium Tc-99m arcitumomab | Quinestrol may increase the thrombogenic activities of Technetium Tc-99m arcitumomab. |
| Eculizumab | Quinestrol may increase the thrombogenic activities of Eculizumab. |
| Panitumumab | Quinestrol may increase the thrombogenic activities of Panitumumab. |
| Ranibizumab | Quinestrol may increase the thrombogenic activities of Ranibizumab. |
| Galiximab | Quinestrol may increase the thrombogenic activities of Galiximab. |
| Pexelizumab | Quinestrol may increase the thrombogenic activities of Pexelizumab. |
| Afelimomab | Quinestrol may increase the thrombogenic activities of Afelimomab. |
| Epratuzumab | Quinestrol may increase the thrombogenic activities of Epratuzumab. |
| Bectumomab | Quinestrol may increase the thrombogenic activities of Bectumomab. |
| Oregovomab | Quinestrol may increase the thrombogenic activities of Oregovomab. |
| IGN311 | Quinestrol may increase the thrombogenic activities of IGN311. |
| Adecatumumab | Quinestrol may increase the thrombogenic activities of Adecatumumab. |
| Labetuzumab | Quinestrol may increase the thrombogenic activities of Labetuzumab. |
| Matuzumab | Quinestrol may increase the thrombogenic activities of Matuzumab. |
| Fontolizumab | Quinestrol may increase the thrombogenic activities of Fontolizumab. |
| Bavituximab | Quinestrol may increase the thrombogenic activities of Bavituximab. |
| CR002 | Quinestrol may increase the thrombogenic activities of CR002. |
| Rozrolimupab | Quinestrol may increase the thrombogenic activities of Rozrolimupab. |
| Girentuximab | Quinestrol may increase the thrombogenic activities of Girentuximab. |
| Obiltoxaximab | Quinestrol may increase the thrombogenic activities of Obiltoxaximab. |
| XTL-001 | Quinestrol may increase the thrombogenic activities of XTL-001. |
| NAV 1800 | Quinestrol may increase the thrombogenic activities of NAV 1800. |
| Briakinumab | Quinestrol may increase the thrombogenic activities of Briakinumab. |
| Otelixizumab | Quinestrol may increase the thrombogenic activities of Otelixizumab. |
| AMG 108 | Quinestrol may increase the thrombogenic activities of AMG 108. |
| Iratumumab | Quinestrol may increase the thrombogenic activities of Iratumumab. |
| Enokizumab | Quinestrol may increase the thrombogenic activities of Enokizumab. |
| Ramucirumab | Quinestrol may increase the thrombogenic activities of Ramucirumab. |
| Farletuzumab | Quinestrol may increase the thrombogenic activities of Farletuzumab. |
| Veltuzumab | Quinestrol may increase the thrombogenic activities of Veltuzumab. |
| Ustekinumab | Quinestrol may increase the thrombogenic activities of Ustekinumab. |
| Trastuzumab emtansine | Quinestrol may increase the thrombogenic activities of Trastuzumab emtansine. |
| PRO-542 | Quinestrol may increase the thrombogenic activities of PRO-542. |
| TNX-901 | Quinestrol may increase the thrombogenic activities of TNX-901. |
| Inotuzumab ozogamicin | Quinestrol may increase the thrombogenic activities of Inotuzumab ozogamicin. |
| RI 624 | Quinestrol may increase the thrombogenic activities of RI 624. |
| Stamulumab | Quinestrol may increase the thrombogenic activities of MYO-029. |
| CT-011 | Quinestrol may increase the thrombogenic activities of CT-011. |
| Leronlimab | Quinestrol may increase the thrombogenic activities of Leronlimab. |
| Glembatumumab vedotin | Quinestrol may increase the thrombogenic activities of Glembatumumab vedotin. |
| Olaratumab | Quinestrol may increase the thrombogenic activities of Olaratumab. |
| IPH 2101 | Quinestrol may increase the thrombogenic activities of IPH 2101. |
| TB-402 | Quinestrol may increase the thrombogenic activities of TB-402. |
| Caplacizumab | Quinestrol may increase the thrombogenic activities of Caplacizumab. |
| IMC-1C11 | Quinestrol may increase the thrombogenic activities of IMC-1C11. |
| Eldelumab | Quinestrol may increase the thrombogenic activities of Eldelumab. |
| Lumiliximab | Quinestrol may increase the thrombogenic activities of Lumiliximab. |
| Canakinumab | Quinestrol may increase the thrombogenic activities of Canakinumab. |
| Ipilimumab | Quinestrol may increase the thrombogenic activities of Ipilimumab. |
| Nimotuzumab | Quinestrol may increase the thrombogenic activities of Nimotuzumab. |
| Clenoliximab | Quinestrol may increase the thrombogenic activities of Clenoliximab. |
| Tocilizumab | Quinestrol may increase the thrombogenic activities of Tocilizumab. |
| BIIB015 | Quinestrol may increase the thrombogenic activities of BIIB015. |
| Sonepcizumab | Quinestrol may increase the thrombogenic activities of Sonepcizumab. |
| Motavizumab | Quinestrol may increase the thrombogenic activities of Motavizumab. |
| Elotuzumab | Quinestrol may increase the thrombogenic activities of Elotuzumab. |
| AVE9633 | Quinestrol may increase the thrombogenic activities of AVE9633. |
| Carotuximab | Quinestrol may increase the thrombogenic activities of Carotuximab. |
| XmAb 2513 | Quinestrol may increase the thrombogenic activities of XmAb 2513. |
| Coltuximab ravtansine | Quinestrol may increase the thrombogenic activities of Coltuximab ravtansine. |
| Lucatumumab | Quinestrol may increase the thrombogenic activities of Lucatumumab. |
| Pertuzumab | Quinestrol may increase the thrombogenic activities of Pertuzumab. |
| Siplizumab | Quinestrol may increase the thrombogenic activities of Siplizumab. |
| Apolizumab | Quinestrol may increase the thrombogenic activities of Apolizumab. |
| Sibrotuzumab | Quinestrol may increase the thrombogenic activities of Sibrotuzumab. |
| Bivatuzumab | Quinestrol may increase the thrombogenic activities of Bivatuzumab. |
| Lerdelimumab | Quinestrol may increase the thrombogenic activities of Lerdelimumab. |
| Lexatumumab | Quinestrol may increase the thrombogenic activities of Lexatumumab. |
| Reslizumab | Quinestrol may increase the thrombogenic activities of Reslizumab. |